Jérôme Guicheux

Prof. Jérôme Guicheux


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2009 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
FWFabien Wauquier
Fabien Wauquier
LLLaurent Leotoing
Laurent Leotoing
VCVéronique Coxam
Véronique Coxam
JGJérôme Guicheux
Jérôme Guicheux
YWYohann Wittrant
Yohann Wittrant

1 May 2009 in Trends in Biotechnology
Verified
Journal Article
Closed access
CVClaire Vinatier
Claire Vinatier
DMDominique Mrugala
Dominique Mrugala
CJChristian Jorgensen
Christian Jorgensen
JGJérôme Guicheux
Jérôme Guicheux
Daniele NoelDaniele Noel
Daniele Noel

1 November 2003 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
PDF file
JGJérôme Guicheux
Jérôme Guicheux
JLJ Lemonnier
J Lemonnier
CGChafik Ghayor
Chafik Ghayor
ASA Suzuki
A Suzuki
GPGaby Palmer
Gaby Palmer
JCJ Caverzasio
J Caverzasio
Signaling involved in osteoblastic cell differentiation remains largely unknown. This study further investigates mechanisms involved in BMP-2-induced osteoblastic cell differentiation. We report that BMP-2 can activate JNK and p38 in osteoblastic cells and provide evidences that these MAP kinases have distinct roles in regulating alkaline phosphatase and osteocalcin expression. Introduction: Bone morphogenetic protein (BMP)-2 exerts many of its biological effects through activation of the Smad pathway. Cooperative interactions between the Smads and the stress-activated protein kinase (SAPK) p38 and c-Jun-NH2-terminal kinase (JNK) pathways have recently been observed in TGF-β signaling. Materials and Methods: Activation of mitogen-activated protein (MAP) kinases by BMP-2 and the role of these signaling pathways for cell differentiation induced by BMP-2 was investigated in mouse MC3T3-E1 and primary cultured calvaria-derived osteoblastic cells using immunoprecipitation, in vitro kinase assay and Western blot analysis, as well as specific MAP kinase inhibitors. Results: Associated with the rapid activation of Smads, BMP-2 barely affected extracellular-signal regulated kinase (ERK) activity, whereas it induced a transient activation of p38 and JNK. The role of p38 and JNK in mediating BMP-2-induced stimulation of osteoblastic cell differentiation was evaluated using the respective specific inhibitors SB203580 and SP600125. Inhibition of p38 by SB203580 was mainly associated with decreased alkaline phosphatase (ALP) activity, whereas inhibition of JNK by SP600125 was associated with a marked reduction in osteocalcin (OC) production induced by BMP-2. Corresponding alterations in ALP and OC mRNA levels were found in cells treated with BMP-2 and inhibitors, suggesting an implication of p38 and JNK pathways in BMP-2-induced osteoblastic cell differentiation at a transcriptional level. Conclusion: Data presented in this study describe p38 and JNK as new signaling pathways involved in BMP-2-induced osteoblastic cell differentiation with evidences for a distinct role of each MAP kinase in the control of alkaline phosphatase and osteocalcin expression.

1 June 2016 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
CVC. Vinatier
C. Vinatier
JGJérôme Guicheux
Jérôme Guicheux

1 January 2005 in Bone
Verified
Journal Article
Closed access
BPB. Peter
B. Peter
DPDominique Pioletti
Dominique Pioletti
SLS. Laïb
S. Laïb
BBB. Bujoli
B. Bujoli
PPP. Pilet
P. Pilet
OGO. Gauthier
O. Gauthier

1 April 2011 in Biomaterials
Verified
Journal Article
Closed access
ECEstelle C. Collin
Estelle C. Collin
SGSibylle Grad
Sibylle Grad
Dimitrios ZeugolisDimitrios Zeugolis
Dimitrios Zeugolis
CVClaire S. Vinatier
Claire S. Vinatier
JCJohann R. Clouet
Johann R. Clouet
Abhay PanditAbhay Pandit
Abhay Pandit